Institutional shares held 30.2 Million
900 calls
6.6K puts
Total value of holdings $738M
$21K calls
$161K puts
Market Cap $10.6B
435,348,000 Shares Out.
Institutional ownership 6.94%
# of Institutions 223


Latest Institutional Activity in SNN

Top Purchases

Q3 2024
River Road Asset Management, LLC Shares Held: 1.24M ($30.3M)
Q3 2024
Goldman Sachs Group Inc Shares Held: 2.43M ($59.5M)
Q3 2024
Heartland Advisors Inc Shares Held: 437K ($10.7M)
Q3 2024
Deprince Race & Zollo Inc Shares Held: 547K ($13.4M)
Q3 2024
Point72 (Difc) LTD Shares Held: 231K ($5.65M)

Top Sells

Q3 2024
Bank Of America Corp Shares Held: 392K ($9.57M)
Q3 2024
Bank Of Montreal Shares Held: 352K ($8.6M)
Q3 2024
Tpg Gp A, LLC Shares Held: 1.48M ($36.3M)
Q3 2024
Balyasny Asset Management LLC Shares Held: 172K ($4.19M)
Q3 2024
Hsbc Holdings PLC Shares Held: 161K ($3.95M)

About SNN

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.


Insider Transactions at SNN

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on SNN

Follow SMITH & NEPHEW PLC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNN shares.

Notify only if

Insider Trading

Get notified when an Smith & Nephew PLC insider buys or sells SNN shares.

Notify only if

News

Receive news related to SMITH & NEPHEW PLC

Track Activities on SNN